Compare Gilead Sciences, Inc. (GILD) vs NetFlix Inc (NFLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs NetFlix Inc — how do they compare? Gilead Sciences, Inc. trades at $134.85 (market cap $163.51B), while NetFlix Inc trades at $73.98 (market cap $310.25B). The key difference: NetFlix Inc is the larger of the two by market cap, and Gilead Sciences, Inc. pays a 2.49% dividend while NetFlix Inc pays none. Which is the better fit depends on your goals.
| GILD | NFLX | |
|---|---|---|
Market Cap | $163.51B | $310.25B |
Sector | Health | Consumer Cyclical |
52-Week High | $155.80 | $127.42 |
52-Week Low | $108.22 | $70.91 |
Enterprise Value | $178.05B | $312.32B |
Dividend Yield | 2.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Netflix (NFLX) trades at $73.53, down 0.41% on the day and approaching its 52-week low. The technical picture remains bearish with strong selling pressure, while fundamentals show robust revenue growth to $45.18B in 2025 and net income of $10.98B. Recent earnings beat expectations with Q1 2026 EPS of $1.23 versus $0.76 expected, though the stock faces negative momentum amid concerns about growth sustainability.
Despite current bearish technicals, Netflix maintains strong fundamentals with 65% analyst buy ratings and a $103.64 consensus price target suggesting 41% upside. Key opportunities include advertising revenue scaling toward $3B by 2026 and expanding global market share. Risks include intense streaming competition and execution challenges in new business verticals like live sports and gaming.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About NetFlix Inc
Netflix Inc. is an Internet subscription service for watching television shows and movies. Subscribers can instantly watch unlimited television shows and movies streamed over the Internet to their televisions, computers, and mobile devices and in the United States, subscribers can receive standard definition DVDs and Blu-ray Discs delivered to their homes.
Read more on NFLX →
